Common blood biomarkers for colorectal cancer, such as the carcinoembryonic antigen (CEA) and carbohydrate antigen 19-9 (CA 19-9), are mainly used to monitor treatment response and detect recurrence as they also have limited sensitivity and specificity in early-stage disease [24]. The gene discussed is CEACAM5; the disease is colorectal cancer.